IDegAsp (Explorative 1)

insulin degludec/aspart · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IDegAsp (Explorative 1), covering 2015-10-22 to 2015-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects [Phase 1]

See pricing